X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (43) 43
hematology (34) 34
humans (32) 32
oncology (24) 24
male (19) 19
female (18) 18
lymphomas (16) 16
aged (15) 15
rituximab (14) 14
middle aged (13) 13
antineoplastic combined chemotherapy protocols - therapeutic use (11) 11
survival (11) 11
aged, 80 and over (10) 10
prognosis (10) 10
chronic lymphocytic-leukemia (9) 9
cyclophosphamide (9) 9
treatment outcome (9) 9
therapy (8) 8
adult (7) 7
lymphoma (7) 7
abridged index medicus (6) 6
immunoglobulin heavy chains - genetics (6) 6
leukemia, lymphocytic, chronic, b-cell - genetics (6) 6
term-follow-up (6) 6
analysis (5) 5
antineoplastic agents - therapeutic use (5) 5
leukemia, lymphocytic, chronic, b-cell - pathology (5) 5
open-label (5) 5
1st-line treatment (4) 4
antimitotic agents (4) 4
antineoplastic agents (4) 4
care and treatment (4) 4
chemotherapy (4) 4
chronic lymphocytic leukaemia (4) 4
disease-free survival (4) 4
follicular lymphoma (4) 4
follow-up studies (4) 4
genomic aberrations (4) 4
indolent (4) 4
leukemia, hairy cell - genetics (4) 4
non-hodgkins-lymphoma (4) 4
phase-ii (4) 4
radiotherapy (4) 4
rituximab - therapeutic use (4) 4
somatic hypermutation (4) 4
toxicity (4) 4
young adult (4) 4
2-chlorodeoxyadenosine (3) 3
animals (3) 3
antibodies, monoclonal, murine-derived - administration & dosage (3) 3
antineoplastic combined chemotherapy protocols - adverse effects (3) 3
b-cell lymphoma (3) 3
bortezomib (3) 3
chemoimmunotherapy (3) 3
cladribine (3) 3
doxorubicin (3) 3
drug administration schedule (3) 3
follow-up (3) 3
hairy cell leukemia (3) 3
hodgkin disease - pathology (3) 3
immunogenetics (3) 3
immunoglobulins (3) 3
lenalidomide (3) 3
leukemia, hairy cell - drug therapy (3) 3
leukemia, lymphocytic, chronic, b-cell - drug therapy (3) 3
leukemia, lymphocytic, chronic, b-cell - mortality (3) 3
medicine & public health (3) 3
multicenter (3) 3
mutation (3) 3
neoplasm staging (3) 3
pathology (3) 3
prednisone (3) 3
single-nucleotide polymorphism (3) 3
survival analysis (3) 3
tumor proteins (3) 3
vidarabine - administration & dosage (3) 3
vidarabine - analogs & derivatives (3) 3
aged patients (2) 2
amino acid sequence (2) 2
anthracyclines (2) 2
antineoplastic agents, immunological - therapeutic use (2) 2
antineoplastic combined chemotherapy protocols - administration & dosage (2) 2
apoptosis (2) 2
association (2) 2
b-lymphocytes - metabolism (2) 2
bendamustine (2) 2
bleomycin - therapeutic use (2) 2
bone marrow - pathology (2) 2
cancer (2) 2
cd38 expression (2) 2
chronic lymphatic leukemia (2) 2
cladribine - therapeutic use (2) 2
cll (2) 2
cns lymphoma (2) 2
cohort studies (2) 2
combination (2) 2
corticosteroids (2) 2
cyclophosphamide - administration & dosage (2) 2
disease progression (2) 2
dosage and administration (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Journal of Pathology, ISSN 0022-3417, 08/2017, Volume 242, Issue 4, pp. 511 - 512
Journal Article
Cancer, ISSN 0008-543X, 10/2015, Volume 121, Issue 20, pp. 3746 - 3747
Journal Article
Hematological Oncology, ISSN 0278-0232, 10/2019, Volume 37, Issue 4, pp. 493 - 495
Journal Article
British Journal of Haematology, ISSN 0007-1048, 09/2018, Volume 182, Issue 5, pp. 741 - 742
Journal Article
American Journal of Hematology, ISSN 0361-8609, 05/2014, Volume 89, Issue 5, pp. 480 - 486
Journal Article
Leukemia & Lymphoma, ISSN 1042-8194, 02/2019, Volume 60, Issue 3, pp. 833 - 835
Journal Article
Blood Research, ISSN 2287-979X, 2018, Volume 53, Issue 2, pp. 174 - 177
KCI Citation Count: 0 
Letter to the Editor | 병리학
Journal Article
Journal Article
Acta Clinica Belgica, ISSN 1784-3286, 11/2018, Volume 73, Issue 6, pp. 408 - 412
Objectives and Methods: High-grade B-cell lymphoma, NOS (HGBL) have an aggressive clinical behavior and poor outcome using regimens currently employed for... 
Aggressive B-NHL | malignant lymphoma | rituximab | HEALTH-ORGANIZATION CLASSIFICATION | MEDICINE, GENERAL & INTERNAL | BURKITT-LYMPHOMA | EFFICACY | CYCLOPHOSPHAMIDE | MYC | DIFFUSE | NON-HODGKINS-LYMPHOMA | FEATURES INTERMEDIATE | Index Medicus
Journal Article
Medical Oncology, ISSN 1357-0560, 2014, Volume 31, Issue 4, p. 1
Journal Article
Medical Oncology, ISSN 1357-0560, 4/2014, Volume 31, Issue 4, pp. 1 - 2
Journal Article
British Journal of Haematology, ISSN 0007-1048, 09/2011, Volume 154, Issue 5, pp. 590 - 599
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.